CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Lynx1 Capital Management LP 10% owner | Sale | −10,000 | $2.51 | $25K | 5,240,000 |
| 2023-05-31 | Lynx1 Capital Management LP 10% owner | Sale | −15,000 | $2.52 | $38K | 5,225,000 |
| 2023-05-31 | Lynx1 Capital Management LP 10% owner | Sale | −400 | $2.51 | $1K | 5,224,600 |
| 2023-04-06 | Klencke Barbara Director | Grant or award · Stock Option (Right to Buy) | +9,146 | 9,146 | ||
| 2023-02-02 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2023-02-02 | SOUTHWELL DAVID P Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2023-02-02 | MacBeath Gavin See Remarks | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-02-02 | Barton Debora Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-12-28 | Silver Brian M. Chief Financial Officer | Purchase | +3,158 | $1.56 | $5K | 32,885 |
| 2022-12-27 | Silver Brian M. Chief Financial Officer | Purchase | +2,842 | $1.50 | $4K | 29,727 |
| 2022-07-25 | SOUTHWELL DAVID P Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-07-25 | Desmarais William Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-07-25 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-07-25 | Silver Brian M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +220,000 | 220,000 | ||
| 2022-07-25 | MacBeath Gavin See Remarks | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-07-05 | Barton Debora Chief Medical Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2022-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +9,146 | 9,146 | ||
| 2022-06-01 | Gruia Gabriela Director | Grant or award · Stock Option (Right to Buy) | +9,146 | 9,146 | ||
| 2022-06-01 | BARBERICH TIMOTHY J Director | Grant or award · Stock Option (Right to Buy) | +9,146 | 9,146 | ||
| 2022-06-01 | Dorton Katina Director | Grant or award · Stock Option (Right to Buy) | +9,146 | 9,146 |
Page 5 of 8 · 144 trades